Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro
1 Section on Oxidative Stress Tissue Injury, Laboratories of Physiological Studies and 2 Metabolic Control, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland; 3 Department of Surgery, Medical School, University of Medicine and Dentistry of New Jers...
Gespeichert in:
Veröffentlicht in: | American journal of physiology. Heart and circulatory physiology 2009-05, Vol.296 (5), p.H1466-H1483 |
---|---|
Hauptverfasser: | , , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | H1483 |
---|---|
container_issue | 5 |
container_start_page | H1466 |
container_title | American journal of physiology. Heart and circulatory physiology |
container_volume | 296 |
creator | Mukhopadhyay, Partha Rajesh, Mohanraj Batkai, Sandor Kashiwaya, Yoshihiro Hasko, Gyorgy Liaudet, Lucas Szabo, Csaba Pacher, Pal |
description | 1 Section on Oxidative Stress Tissue Injury, Laboratories of Physiological Studies and 2 Metabolic Control, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland; 3 Department of Surgery, Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey; 4 Department of Intensive Care Medicine, University Hospital, Lausanne, Switzerland; and 5 Department of Anesthesiology, The University of Texas Medical Branch, Galveston, Texas
Submitted 30 July 2008
; accepted in final form 9 March 2009
Doxorubicin (DOX) is a potent available antitumor agent; however, its clinical use is limited because of its cardiotoxicity. Cell death is a key component in DOX-induced cardiotoxicity, but its mechanisms are elusive. Here, we explore the role of superoxide, nitric oxide (NO), and peroxynitrite in DOX-induced cell death using both in vivo and in vitro models of cardiotoxicity. Western blot analysis, real-time PCR, immunohistochemistry, flow cytometry, fluorescent microscopy, and biochemical assays were used to determine the markers of apoptosis/necrosis and sources of NO and superoxide and their production. Left ventricular function was measured by a pressure-volume system. We demonstrated increases in myocardial apoptosis (caspase-3 cleavage/activity, cytochrome c release, and TUNEL), inducible NO synthase (iNOS) expression, mitochondrial superoxide generation, 3-nitrotyrosine (NT) formation, matrix metalloproteinase (MMP)-2/MMP-9 gene expression, poly(ADP-ribose) polymerase activation [without major changes in NAD(P)H oxidase isoform 1, NAD(P)H oxidase isoform 2, p22 phox , p40 phox , p47 phox , p67 phox , xanthine oxidase, endothelial NOS, and neuronal NOS expression] and decreases in myocardial contractility, catalase, and glutathione peroxidase activities 5 days after DOX treatment to mice. All these effects of DOX were markedly attenuated by peroxynitrite scavengers. Doxorubicin dose dependently increased mitochondrial superoxide and NT generation and apoptosis/necrosis in cardiac-derived H9c2 cells. DOX- or peroxynitrite-induced apoptosis/necrosis positively correlated with intracellular NT formation and could be abolished by peroxynitrite scavengers. DOX-induced cell death and NT formation were also attenuated by selective iNOS inhibitors or in iNOS knockout mice. Various NO donors when coadministered with DOX but not alone dramatically enhanced DOX-induced cell death with concomitant increased N |
doi_str_mv | 10.1152/ajpheart.00795.2008 |
format | Article |
fullrecord | <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmed_primary_19286953</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>1702224361</sourcerecordid><originalsourceid>FETCH-LOGICAL-c536t-d0d36e601ac730f13bf6dafd02ac307a6cb4a067ed7c59b848e26b83bce08b133</originalsourceid><addsrcrecordid>eNpVUV1r2zAUFWNlSbP9gsEQe67TKymS7ZfBKOsHFAalfRaydB0rOJYn21nz7-s4Wds96UrnQ4d7CPnKYMmY5Jdm01ZoYr8ESHO55ADZBzIfEZ4wKfKPZA5CiUQxIWfkvOs2ACBTJT6RGct5pnIp5mTzEGqkoaTd0GIMz97hBW18H72lp5tpHJ2w_fTeI_UNdeE5xKHw1jeJb9xg0VGLdU0dmr46MHZ-FybtNPcxfCZnpak7_HI6F-Tp-tfj1W1y__vm7urnfWKlUH3iwAmFCpixqYCSiaJUzpQOuLECUqNssTKgUnSplXmRrTLkqshEYRGyggmxID-Ovu1QbNFZbPpoat1GvzVxr4Px-n-k8ZVeh53mKhsTwGjw_WQQw58Bu15vwhCbMbPmPJdZKsf9Log4kmwMXRexfP2AgT70o__1o6d-9KGfUfXtfbY3zamQkXB5JFR-Xf31EXVb7Tsf6rDevznyXGmpb9lKKfEC4Q2h5Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>229587515</pqid></control><display><type>article</type><title>Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro</title><source>MEDLINE</source><source>American Physiological Society</source><source>EZB-FREE-00999 freely available EZB journals</source><source>Alma/SFX Local Collection</source><creator>Mukhopadhyay, Partha ; Rajesh, Mohanraj ; Batkai, Sandor ; Kashiwaya, Yoshihiro ; Hasko, Gyorgy ; Liaudet, Lucas ; Szabo, Csaba ; Pacher, Pal</creator><creatorcontrib>Mukhopadhyay, Partha ; Rajesh, Mohanraj ; Batkai, Sandor ; Kashiwaya, Yoshihiro ; Hasko, Gyorgy ; Liaudet, Lucas ; Szabo, Csaba ; Pacher, Pal</creatorcontrib><description>1 Section on Oxidative Stress Tissue Injury, Laboratories of Physiological Studies and 2 Metabolic Control, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland; 3 Department of Surgery, Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey; 4 Department of Intensive Care Medicine, University Hospital, Lausanne, Switzerland; and 5 Department of Anesthesiology, The University of Texas Medical Branch, Galveston, Texas
Submitted 30 July 2008
; accepted in final form 9 March 2009
Doxorubicin (DOX) is a potent available antitumor agent; however, its clinical use is limited because of its cardiotoxicity. Cell death is a key component in DOX-induced cardiotoxicity, but its mechanisms are elusive. Here, we explore the role of superoxide, nitric oxide (NO), and peroxynitrite in DOX-induced cell death using both in vivo and in vitro models of cardiotoxicity. Western blot analysis, real-time PCR, immunohistochemistry, flow cytometry, fluorescent microscopy, and biochemical assays were used to determine the markers of apoptosis/necrosis and sources of NO and superoxide and their production. Left ventricular function was measured by a pressure-volume system. We demonstrated increases in myocardial apoptosis (caspase-3 cleavage/activity, cytochrome c release, and TUNEL), inducible NO synthase (iNOS) expression, mitochondrial superoxide generation, 3-nitrotyrosine (NT) formation, matrix metalloproteinase (MMP)-2/MMP-9 gene expression, poly(ADP-ribose) polymerase activation [without major changes in NAD(P)H oxidase isoform 1, NAD(P)H oxidase isoform 2, p22 phox , p40 phox , p47 phox , p67 phox , xanthine oxidase, endothelial NOS, and neuronal NOS expression] and decreases in myocardial contractility, catalase, and glutathione peroxidase activities 5 days after DOX treatment to mice. All these effects of DOX were markedly attenuated by peroxynitrite scavengers. Doxorubicin dose dependently increased mitochondrial superoxide and NT generation and apoptosis/necrosis in cardiac-derived H9c2 cells. DOX- or peroxynitrite-induced apoptosis/necrosis positively correlated with intracellular NT formation and could be abolished by peroxynitrite scavengers. DOX-induced cell death and NT formation were also attenuated by selective iNOS inhibitors or in iNOS knockout mice. Various NO donors when coadministered with DOX but not alone dramatically enhanced DOX-induced cell death with concomitant increased NT formation. DOX-induced cell death was also attenuated by cell-permeable SOD but not by cell-permeable catalase, the xanthine oxidase inhibitor allopurinol, or the NADPH oxidase inhibitors apocynine or diphenylene iodonium. Thus, peroxynitrite is a major trigger of DOX-induced cell death both in vivo and in vivo, and the modulation of the pathways leading to its generation or its effective neutralization can be of significant therapeutic benefit.
heart failure; apoptosis; inducible nitric oxide synthase; hemodynamics
Address for reprint requests and other correspondence: P. Pacher, Section on Oxidative Stress and Tissue Injury, Laboratory of Physiological Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5625 Fishers Lane, MSC-9413, Bethesda, MD 20892-9413 (e-mail: pacher{at}mail.nih.gov )</description><identifier>ISSN: 0363-6135</identifier><identifier>EISSN: 1522-1539</identifier><identifier>DOI: 10.1152/ajpheart.00795.2008</identifier><identifier>PMID: 19286953</identifier><identifier>CODEN: AJPPDI</identifier><language>eng</language><publisher>United States: American Physiological Society</publisher><subject>Animals ; Antibiotics, Antineoplastic - toxicity ; Antioxidants - metabolism ; Apoptosis ; Apoptosis - drug effects ; Cell Line ; Cells ; Dose-Response Relationship, Drug ; Doxorubicin - toxicity ; Enzyme Inhibitors - pharmacology ; Free Radical Scavengers - pharmacology ; Heart Diseases - chemically induced ; Heart Diseases - metabolism ; Heart Diseases - pathology ; Heart Diseases - physiopathology ; Heart Diseases - prevention & control ; Male ; Matrix Metalloproteinase 2 - metabolism ; Matrix Metalloproteinase 9 - metabolism ; Mice ; Mice, Inbred C57BL ; Mice, Knockout ; Mitochondria, Heart - drug effects ; Mitochondria, Heart - metabolism ; Mitochondria, Heart - pathology ; Myocardial Contraction - drug effects ; Myocytes, Cardiac - drug effects ; Myocytes, Cardiac - metabolism ; Myocytes, Cardiac - pathology ; Necrosis ; Nitric oxide ; Nitric Oxide - metabolism ; Nitric Oxide Donors - pharmacology ; Nitric Oxide Synthase Type II - antagonists & inhibitors ; Nitric Oxide Synthase Type II - deficiency ; Nitric Oxide Synthase Type II - genetics ; Permeability ; Peroxynitrous Acid - metabolism ; Poly(ADP-ribose) Polymerases - metabolism ; Rodents ; Superoxides - metabolism ; Toxicity ; Tumors ; Tyrosine - analogs & derivatives ; Tyrosine - metabolism ; Ventricular Function, Left - drug effects ; Ventricular Pressure - drug effects</subject><ispartof>American journal of physiology. Heart and circulatory physiology, 2009-05, Vol.296 (5), p.H1466-H1483</ispartof><rights>Copyright American Physiological Society May 2009</rights><rights>Copyright © 2009, American Physiological Society</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c536t-d0d36e601ac730f13bf6dafd02ac307a6cb4a067ed7c59b848e26b83bce08b133</citedby><cites>FETCH-LOGICAL-c536t-d0d36e601ac730f13bf6dafd02ac307a6cb4a067ed7c59b848e26b83bce08b133</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>230,314,780,784,885,3039,27924,27925</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19286953$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Mukhopadhyay, Partha</creatorcontrib><creatorcontrib>Rajesh, Mohanraj</creatorcontrib><creatorcontrib>Batkai, Sandor</creatorcontrib><creatorcontrib>Kashiwaya, Yoshihiro</creatorcontrib><creatorcontrib>Hasko, Gyorgy</creatorcontrib><creatorcontrib>Liaudet, Lucas</creatorcontrib><creatorcontrib>Szabo, Csaba</creatorcontrib><creatorcontrib>Pacher, Pal</creatorcontrib><title>Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro</title><title>American journal of physiology. Heart and circulatory physiology</title><addtitle>Am J Physiol Heart Circ Physiol</addtitle><description>1 Section on Oxidative Stress Tissue Injury, Laboratories of Physiological Studies and 2 Metabolic Control, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland; 3 Department of Surgery, Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey; 4 Department of Intensive Care Medicine, University Hospital, Lausanne, Switzerland; and 5 Department of Anesthesiology, The University of Texas Medical Branch, Galveston, Texas
Submitted 30 July 2008
; accepted in final form 9 March 2009
Doxorubicin (DOX) is a potent available antitumor agent; however, its clinical use is limited because of its cardiotoxicity. Cell death is a key component in DOX-induced cardiotoxicity, but its mechanisms are elusive. Here, we explore the role of superoxide, nitric oxide (NO), and peroxynitrite in DOX-induced cell death using both in vivo and in vitro models of cardiotoxicity. Western blot analysis, real-time PCR, immunohistochemistry, flow cytometry, fluorescent microscopy, and biochemical assays were used to determine the markers of apoptosis/necrosis and sources of NO and superoxide and their production. Left ventricular function was measured by a pressure-volume system. We demonstrated increases in myocardial apoptosis (caspase-3 cleavage/activity, cytochrome c release, and TUNEL), inducible NO synthase (iNOS) expression, mitochondrial superoxide generation, 3-nitrotyrosine (NT) formation, matrix metalloproteinase (MMP)-2/MMP-9 gene expression, poly(ADP-ribose) polymerase activation [without major changes in NAD(P)H oxidase isoform 1, NAD(P)H oxidase isoform 2, p22 phox , p40 phox , p47 phox , p67 phox , xanthine oxidase, endothelial NOS, and neuronal NOS expression] and decreases in myocardial contractility, catalase, and glutathione peroxidase activities 5 days after DOX treatment to mice. All these effects of DOX were markedly attenuated by peroxynitrite scavengers. Doxorubicin dose dependently increased mitochondrial superoxide and NT generation and apoptosis/necrosis in cardiac-derived H9c2 cells. DOX- or peroxynitrite-induced apoptosis/necrosis positively correlated with intracellular NT formation and could be abolished by peroxynitrite scavengers. DOX-induced cell death and NT formation were also attenuated by selective iNOS inhibitors or in iNOS knockout mice. Various NO donors when coadministered with DOX but not alone dramatically enhanced DOX-induced cell death with concomitant increased NT formation. DOX-induced cell death was also attenuated by cell-permeable SOD but not by cell-permeable catalase, the xanthine oxidase inhibitor allopurinol, or the NADPH oxidase inhibitors apocynine or diphenylene iodonium. Thus, peroxynitrite is a major trigger of DOX-induced cell death both in vivo and in vivo, and the modulation of the pathways leading to its generation or its effective neutralization can be of significant therapeutic benefit.
heart failure; apoptosis; inducible nitric oxide synthase; hemodynamics
Address for reprint requests and other correspondence: P. Pacher, Section on Oxidative Stress and Tissue Injury, Laboratory of Physiological Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5625 Fishers Lane, MSC-9413, Bethesda, MD 20892-9413 (e-mail: pacher{at}mail.nih.gov )</description><subject>Animals</subject><subject>Antibiotics, Antineoplastic - toxicity</subject><subject>Antioxidants - metabolism</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Cell Line</subject><subject>Cells</subject><subject>Dose-Response Relationship, Drug</subject><subject>Doxorubicin - toxicity</subject><subject>Enzyme Inhibitors - pharmacology</subject><subject>Free Radical Scavengers - pharmacology</subject><subject>Heart Diseases - chemically induced</subject><subject>Heart Diseases - metabolism</subject><subject>Heart Diseases - pathology</subject><subject>Heart Diseases - physiopathology</subject><subject>Heart Diseases - prevention & control</subject><subject>Male</subject><subject>Matrix Metalloproteinase 2 - metabolism</subject><subject>Matrix Metalloproteinase 9 - metabolism</subject><subject>Mice</subject><subject>Mice, Inbred C57BL</subject><subject>Mice, Knockout</subject><subject>Mitochondria, Heart - drug effects</subject><subject>Mitochondria, Heart - metabolism</subject><subject>Mitochondria, Heart - pathology</subject><subject>Myocardial Contraction - drug effects</subject><subject>Myocytes, Cardiac - drug effects</subject><subject>Myocytes, Cardiac - metabolism</subject><subject>Myocytes, Cardiac - pathology</subject><subject>Necrosis</subject><subject>Nitric oxide</subject><subject>Nitric Oxide - metabolism</subject><subject>Nitric Oxide Donors - pharmacology</subject><subject>Nitric Oxide Synthase Type II - antagonists & inhibitors</subject><subject>Nitric Oxide Synthase Type II - deficiency</subject><subject>Nitric Oxide Synthase Type II - genetics</subject><subject>Permeability</subject><subject>Peroxynitrous Acid - metabolism</subject><subject>Poly(ADP-ribose) Polymerases - metabolism</subject><subject>Rodents</subject><subject>Superoxides - metabolism</subject><subject>Toxicity</subject><subject>Tumors</subject><subject>Tyrosine - analogs & derivatives</subject><subject>Tyrosine - metabolism</subject><subject>Ventricular Function, Left - drug effects</subject><subject>Ventricular Pressure - drug effects</subject><issn>0363-6135</issn><issn>1522-1539</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpVUV1r2zAUFWNlSbP9gsEQe67TKymS7ZfBKOsHFAalfRaydB0rOJYn21nz7-s4Wds96UrnQ4d7CPnKYMmY5Jdm01ZoYr8ESHO55ADZBzIfEZ4wKfKPZA5CiUQxIWfkvOs2ACBTJT6RGct5pnIp5mTzEGqkoaTd0GIMz97hBW18H72lp5tpHJ2w_fTeI_UNdeE5xKHw1jeJb9xg0VGLdU0dmr46MHZ-FybtNPcxfCZnpak7_HI6F-Tp-tfj1W1y__vm7urnfWKlUH3iwAmFCpixqYCSiaJUzpQOuLECUqNssTKgUnSplXmRrTLkqshEYRGyggmxID-Ovu1QbNFZbPpoat1GvzVxr4Px-n-k8ZVeh53mKhsTwGjw_WQQw58Bu15vwhCbMbPmPJdZKsf9Log4kmwMXRexfP2AgT70o__1o6d-9KGfUfXtfbY3zamQkXB5JFR-Xf31EXVb7Tsf6rDevznyXGmpb9lKKfEC4Q2h5Q</recordid><startdate>20090501</startdate><enddate>20090501</enddate><creator>Mukhopadhyay, Partha</creator><creator>Rajesh, Mohanraj</creator><creator>Batkai, Sandor</creator><creator>Kashiwaya, Yoshihiro</creator><creator>Hasko, Gyorgy</creator><creator>Liaudet, Lucas</creator><creator>Szabo, Csaba</creator><creator>Pacher, Pal</creator><general>American Physiological Society</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7QP</scope><scope>7QR</scope><scope>7TS</scope><scope>7U7</scope><scope>8FD</scope><scope>C1K</scope><scope>FR3</scope><scope>P64</scope><scope>5PM</scope></search><sort><creationdate>20090501</creationdate><title>Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro</title><author>Mukhopadhyay, Partha ; Rajesh, Mohanraj ; Batkai, Sandor ; Kashiwaya, Yoshihiro ; Hasko, Gyorgy ; Liaudet, Lucas ; Szabo, Csaba ; Pacher, Pal</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c536t-d0d36e601ac730f13bf6dafd02ac307a6cb4a067ed7c59b848e26b83bce08b133</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Animals</topic><topic>Antibiotics, Antineoplastic - toxicity</topic><topic>Antioxidants - metabolism</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Cell Line</topic><topic>Cells</topic><topic>Dose-Response Relationship, Drug</topic><topic>Doxorubicin - toxicity</topic><topic>Enzyme Inhibitors - pharmacology</topic><topic>Free Radical Scavengers - pharmacology</topic><topic>Heart Diseases - chemically induced</topic><topic>Heart Diseases - metabolism</topic><topic>Heart Diseases - pathology</topic><topic>Heart Diseases - physiopathology</topic><topic>Heart Diseases - prevention & control</topic><topic>Male</topic><topic>Matrix Metalloproteinase 2 - metabolism</topic><topic>Matrix Metalloproteinase 9 - metabolism</topic><topic>Mice</topic><topic>Mice, Inbred C57BL</topic><topic>Mice, Knockout</topic><topic>Mitochondria, Heart - drug effects</topic><topic>Mitochondria, Heart - metabolism</topic><topic>Mitochondria, Heart - pathology</topic><topic>Myocardial Contraction - drug effects</topic><topic>Myocytes, Cardiac - drug effects</topic><topic>Myocytes, Cardiac - metabolism</topic><topic>Myocytes, Cardiac - pathology</topic><topic>Necrosis</topic><topic>Nitric oxide</topic><topic>Nitric Oxide - metabolism</topic><topic>Nitric Oxide Donors - pharmacology</topic><topic>Nitric Oxide Synthase Type II - antagonists & inhibitors</topic><topic>Nitric Oxide Synthase Type II - deficiency</topic><topic>Nitric Oxide Synthase Type II - genetics</topic><topic>Permeability</topic><topic>Peroxynitrous Acid - metabolism</topic><topic>Poly(ADP-ribose) Polymerases - metabolism</topic><topic>Rodents</topic><topic>Superoxides - metabolism</topic><topic>Toxicity</topic><topic>Tumors</topic><topic>Tyrosine - analogs & derivatives</topic><topic>Tyrosine - metabolism</topic><topic>Ventricular Function, Left - drug effects</topic><topic>Ventricular Pressure - drug effects</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Mukhopadhyay, Partha</creatorcontrib><creatorcontrib>Rajesh, Mohanraj</creatorcontrib><creatorcontrib>Batkai, Sandor</creatorcontrib><creatorcontrib>Kashiwaya, Yoshihiro</creatorcontrib><creatorcontrib>Hasko, Gyorgy</creatorcontrib><creatorcontrib>Liaudet, Lucas</creatorcontrib><creatorcontrib>Szabo, Csaba</creatorcontrib><creatorcontrib>Pacher, Pal</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Calcium & Calcified Tissue Abstracts</collection><collection>Chemoreception Abstracts</collection><collection>Physical Education Index</collection><collection>Toxicology Abstracts</collection><collection>Technology Research Database</collection><collection>Environmental Sciences and Pollution Management</collection><collection>Engineering Research Database</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Mukhopadhyay, Partha</au><au>Rajesh, Mohanraj</au><au>Batkai, Sandor</au><au>Kashiwaya, Yoshihiro</au><au>Hasko, Gyorgy</au><au>Liaudet, Lucas</au><au>Szabo, Csaba</au><au>Pacher, Pal</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro</atitle><jtitle>American journal of physiology. Heart and circulatory physiology</jtitle><addtitle>Am J Physiol Heart Circ Physiol</addtitle><date>2009-05-01</date><risdate>2009</risdate><volume>296</volume><issue>5</issue><spage>H1466</spage><epage>H1483</epage><pages>H1466-H1483</pages><issn>0363-6135</issn><eissn>1522-1539</eissn><coden>AJPPDI</coden><abstract>1 Section on Oxidative Stress Tissue Injury, Laboratories of Physiological Studies and 2 Metabolic Control, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, Bethesda, Maryland; 3 Department of Surgery, Medical School, University of Medicine and Dentistry of New Jersey, Newark, New Jersey; 4 Department of Intensive Care Medicine, University Hospital, Lausanne, Switzerland; and 5 Department of Anesthesiology, The University of Texas Medical Branch, Galveston, Texas
Submitted 30 July 2008
; accepted in final form 9 March 2009
Doxorubicin (DOX) is a potent available antitumor agent; however, its clinical use is limited because of its cardiotoxicity. Cell death is a key component in DOX-induced cardiotoxicity, but its mechanisms are elusive. Here, we explore the role of superoxide, nitric oxide (NO), and peroxynitrite in DOX-induced cell death using both in vivo and in vitro models of cardiotoxicity. Western blot analysis, real-time PCR, immunohistochemistry, flow cytometry, fluorescent microscopy, and biochemical assays were used to determine the markers of apoptosis/necrosis and sources of NO and superoxide and their production. Left ventricular function was measured by a pressure-volume system. We demonstrated increases in myocardial apoptosis (caspase-3 cleavage/activity, cytochrome c release, and TUNEL), inducible NO synthase (iNOS) expression, mitochondrial superoxide generation, 3-nitrotyrosine (NT) formation, matrix metalloproteinase (MMP)-2/MMP-9 gene expression, poly(ADP-ribose) polymerase activation [without major changes in NAD(P)H oxidase isoform 1, NAD(P)H oxidase isoform 2, p22 phox , p40 phox , p47 phox , p67 phox , xanthine oxidase, endothelial NOS, and neuronal NOS expression] and decreases in myocardial contractility, catalase, and glutathione peroxidase activities 5 days after DOX treatment to mice. All these effects of DOX were markedly attenuated by peroxynitrite scavengers. Doxorubicin dose dependently increased mitochondrial superoxide and NT generation and apoptosis/necrosis in cardiac-derived H9c2 cells. DOX- or peroxynitrite-induced apoptosis/necrosis positively correlated with intracellular NT formation and could be abolished by peroxynitrite scavengers. DOX-induced cell death and NT formation were also attenuated by selective iNOS inhibitors or in iNOS knockout mice. Various NO donors when coadministered with DOX but not alone dramatically enhanced DOX-induced cell death with concomitant increased NT formation. DOX-induced cell death was also attenuated by cell-permeable SOD but not by cell-permeable catalase, the xanthine oxidase inhibitor allopurinol, or the NADPH oxidase inhibitors apocynine or diphenylene iodonium. Thus, peroxynitrite is a major trigger of DOX-induced cell death both in vivo and in vivo, and the modulation of the pathways leading to its generation or its effective neutralization can be of significant therapeutic benefit.
heart failure; apoptosis; inducible nitric oxide synthase; hemodynamics
Address for reprint requests and other correspondence: P. Pacher, Section on Oxidative Stress and Tissue Injury, Laboratory of Physiological Studies, National Institute on Alcohol Abuse and Alcoholism, National Institutes of Health, 5625 Fishers Lane, MSC-9413, Bethesda, MD 20892-9413 (e-mail: pacher{at}mail.nih.gov )</abstract><cop>United States</cop><pub>American Physiological Society</pub><pmid>19286953</pmid><doi>10.1152/ajpheart.00795.2008</doi><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0363-6135 |
ispartof | American journal of physiology. Heart and circulatory physiology, 2009-05, Vol.296 (5), p.H1466-H1483 |
issn | 0363-6135 1522-1539 |
language | eng |
recordid | cdi_pubmed_primary_19286953 |
source | MEDLINE; American Physiological Society; EZB-FREE-00999 freely available EZB journals; Alma/SFX Local Collection |
subjects | Animals Antibiotics, Antineoplastic - toxicity Antioxidants - metabolism Apoptosis Apoptosis - drug effects Cell Line Cells Dose-Response Relationship, Drug Doxorubicin - toxicity Enzyme Inhibitors - pharmacology Free Radical Scavengers - pharmacology Heart Diseases - chemically induced Heart Diseases - metabolism Heart Diseases - pathology Heart Diseases - physiopathology Heart Diseases - prevention & control Male Matrix Metalloproteinase 2 - metabolism Matrix Metalloproteinase 9 - metabolism Mice Mice, Inbred C57BL Mice, Knockout Mitochondria, Heart - drug effects Mitochondria, Heart - metabolism Mitochondria, Heart - pathology Myocardial Contraction - drug effects Myocytes, Cardiac - drug effects Myocytes, Cardiac - metabolism Myocytes, Cardiac - pathology Necrosis Nitric oxide Nitric Oxide - metabolism Nitric Oxide Donors - pharmacology Nitric Oxide Synthase Type II - antagonists & inhibitors Nitric Oxide Synthase Type II - deficiency Nitric Oxide Synthase Type II - genetics Permeability Peroxynitrous Acid - metabolism Poly(ADP-ribose) Polymerases - metabolism Rodents Superoxides - metabolism Toxicity Tumors Tyrosine - analogs & derivatives Tyrosine - metabolism Ventricular Function, Left - drug effects Ventricular Pressure - drug effects |
title | Role of superoxide, nitric oxide, and peroxynitrite in doxorubicin-induced cell death in vivo and in vitro |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T02%3A37%3A59IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Role%20of%20superoxide,%20nitric%20oxide,%20and%20peroxynitrite%20in%20doxorubicin-induced%20cell%20death%20in%20vivo%20and%20in%20vitro&rft.jtitle=American%20journal%20of%20physiology.%20Heart%20and%20circulatory%20physiology&rft.au=Mukhopadhyay,%20Partha&rft.date=2009-05-01&rft.volume=296&rft.issue=5&rft.spage=H1466&rft.epage=H1483&rft.pages=H1466-H1483&rft.issn=0363-6135&rft.eissn=1522-1539&rft.coden=AJPPDI&rft_id=info:doi/10.1152/ajpheart.00795.2008&rft_dat=%3Cproquest_pubme%3E1702224361%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=229587515&rft_id=info:pmid/19286953&rfr_iscdi=true |